• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Retinal Perfusion Rose Over Time in Preliminary Bedside Sepsis Angiography Study

by
November 17, 2026
in Health
Reading Time: 4 mins read
0
Retinal Perfusion Rose Over Time in Preliminary Bedside Sepsis Angiography Study

Retinal Perfusion Rose Over Time in Preliminary Bedside Sepsis Angiography Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bedside retinal optical coherence tomography angiography tracked daily increases in microvascular perfusion among adults undergoing vasopressor therapy for sepsis-associated circulatory dysfunction, according to exploratory findings from a prospective observational study. Researchers evaluated serial full-region retinal perfusion density across repeat hospital assessments and observed that microvascular vessel density increased by an estimated 1.86 percentage points per nominal day. The preliminary investigation demonstrated the feasibility of performing repeated non-invasive microcirculatory imaging directly at the intensive care bedside in critically ill patients, although significant methodological constraints and patient attrition limit broader physiological conclusions.

Retinal optical coherence tomography angiography has recently emerged as a bedside technique capable of providing non-invasive, objective assessments of retinal microcirculation, yet whether serial imaging can reliably capture microvascular shifts during active vasopressor management has remained uncertain. To explore this capability, clinicians conducted a prospective investigation registered under clinical trial identifier NCT04593212 at Hospital da Luz Lisboa between February 2023 and October 2024. The protocol screened adult patients at the time of diagnosis who exhibited sepsis accompanied by cardiovascular Sequential Organ Failure Assessment scores of three or greater. While the original protocol planned an expansion to 165 participants, acute funding constraints and the termination of an imaging device loan curtailed recruitment. Ultimately, 56 patients underwent screening, 30 enrolled, 29 completed valid baseline imaging, and 13 underwent serial examinations. Hyperlactataemia was not an eligibility requirement for study entry, and baseline scans from four patients had appeared in prior published work.

Under the established protocol, patient screening occurred promptly at diagnosis, requiring both formal study enrolment and an initial imaging examination within the first 24 hours. Follow-up imaging sessions were scheduled at 24-hour intervals for as long as patients continued receiving active vasopressor infusions. Investigators captured superficial 6-by-6-millimetre retinal angiograms using a Cirrus 6000 AngioPlex system, enforcing strict image quality standards that required a Signal Strength of seven or higher alongside systematic artefact screening. All image assessments were conducted in a blinded manner without access to clinical records. Prior to examining longitudinal trajectories, researchers selected full-region perfusion density across the Early Treatment Diabetic Retinopathy Study grid—defined as the perfused fraction of the entire grid on a scale from zero to one—as the primary outcome metric.

The 13 patients who underwent serial imaging contributed a total of 34 bedside examinations and 68 eye-level observations, though participant numbers progressively declined across consecutive assessments. Specifically, 13 patients contributed data at assessments one and two, five patients remained at assessment three, two remained at assessment four, and only one patient completed assessment five. Baseline median perfusion density across the cohort was 38.7 percent. Using a restricted-maximum-likelihood linear mixed-effects model based on binocular mean perfusion density, fixed effects for study day, and patient-specific random intercepts, perfusion density rose by 1.86 percentage points per nominal day, supported by a Wald 95 percent confidence interval of 0.32 to 3.39 (p = 0.018) and a bootstrap 95 percent confidence interval of 0.57 to 4.04 across 10,000 patient-level resamples. Between the first two consecutive examinations, perfusion density rose in 11 of the 13 patients, though the mean paired difference was imprecise at 2.94 percentage points with a 95 percent confidence interval spanning from -0.92 to 6.80. In an exploratory subgroup analysis restricted to nine patients fulfilling strict Sepsis-3 septic shock criteria, the bootstrap confidence interval crossed zero, ranging from -0.06 to 3.49 percentage points per day.

The investigators additionally evaluated the relationship between retinal microvascular density and vasopressor intensity using the vasopressor score, which was calculated from mean weight-adjusted infusion rates derived from cumulative 24-hour drug doses. In univariable analysis, higher vasopressor scores demonstrated a statistically significant association with lower retinal perfusion density, showing a regression coefficient of -0.00143 (p = 0.031). However, when study day and vasopressor score were incorporated together into a mutually adjusted regression model, neither variable maintained statistical significance, yielding p-values of 0.298 for study day and 0.491 for vasopressor score. A strong negative within-patient correlation of -0.77 between study day and vasopressor score revealed substantial collinearity between treatment weaning and time, demonstrating that these statistical associations cannot establish a shared physiological mechanism.

Discontinuation of serial imaging occurred predominantly due to clinical improvement, with 14 patients stopping examinations after vasopressor discontinuation, one patient missing follow-up due to technical difficulties, and another patient discontinuing because of hospital transfer. Consequently, the study follow-up was highly informative: rapidly recovering individuals ceased contributing data as their hemodynamic instability resolved, whereas patients with protracted shock requiring extended vasopressor support remained under observation longer. The researchers noted that statistical bootstrap resampling cannot adjust for this informative dropout pattern, and the longitudinal effect estimates did not formally correct for the informative discontinuation of patient follow-up.

The investigation carried several important limitations that temper the clinical interpretation of the findings, including its small sample size, single-centre execution, the absence of formal repeatability assessments, and vulnerability to unmeasured time-varying confounding. Crucially, in the absence of an established reference standard for microcirculatory monitoring, shifts in retinal perfusion density cannot confirm systemic microvascular recovery or indicate prognostic utility. The authors concluded that serial bedside retinal optical coherence tomography angiography is technically feasible in critically ill patients and that perfusion density correlates positively with observation time, but emphasized that larger longitudinal studies are necessary to determine whether retinal vascular monitoring provides insights beyond conventional hemodynamic measurements or anticipates clinical recovery.

Subject of Research: Serial bedside retinal optical coherence tomography angiography in sepsis-associated circulatory dysfunction

Article Title: Serial bedside retinal optical coherence tomography angiography in sepsis associated circulatory dysfunction

Article References: Alexandre, A. R., Magalhães, G. M., Póvoa, P., & SshOCTA study group (2026). Serial bedside retinal optical coherence tomography angiography in sepsis associated circulatory dysfunction. Intensive Care Medicine Experimental, 14(1), Article 141. https://doi.org/10.1186/s40635-026-00993-3

Image Credits: AI Generated

DOI: 10.1186/s40635-026-00993-3

Keywords: optical coherence tomography angiography, retinal microcirculation, sepsis-associated circulatory dysfunction, perfusion density, vasopressors, intensive care medicine, bedside imaging, Sequential Organ Failure Assessment, ETDRS grid, Cirrus 6000 AngioPlex, microvascular monitoring, Sepsis-3 shock criteria, vasopressor score, hemodynamic monitoring, linear mixed-effects models, informative censoring, Hospital da Luz Lisboa, critical care research

News Source: Ophelia Keating. (November 17, 2026). Retinal Perfusion Rose Over Time in Preliminary Bedside Sepsis Angiography Study. Scienmag.

Tags: bedside imagingCirrus 6000 AngioPlexCritical care researchETDRS gridhemodynamic monitoringHospital da Luz Lisboainformative censoringintensive care medicinelinear mixed-effects modelsmicrovascular monitoringoptical coherence tomography angiographyperfusion densityretinal microcirculationSepsis-3 shock criteriasepsis-associated circulatory dysfunctionSequential Organ Failure Assessmentvasopressor scorevasopressors
Share12Tweet7Share2ShareShareShare1

Related Posts

Three-Dimensional Tumor Spheroids Uncover Critical Barriers Limiting Nanoparticle Cancer Theranostics

Three-Dimensional Tumor Spheroids Uncover Critical Barriers Limiting Nanoparticle Cancer Theranostics

November 18, 2026
Steroid Therapy for Posterior Scleritis Unmasks Peripapillary Pachychoroid Syndrome in Clinical Case

Steroid Therapy for Posterior Scleritis Unmasks Peripapillary Pachychoroid Syndrome in Clinical Case

November 18, 2026

Composite Hypertension Indices Outperform Traditional Obesity Metrics in Jilin Study

November 18, 2026

Case Report Describes Suspected Great Auricular Nerve Injury After Jugular Vein Catheterization

November 18, 2026

POPULAR NEWS

  • Survey Reveals Lack of Parental Awareness Regarding Sibling Visitation Policies in PICUs

    Survey Reveals Lack of Parental Awareness Regarding Sibling Visitation Policies in PICUs

    29 shares
    Share 12 Tweet 7
  • Review Details How Circulating Tumor Cells Survive Bloodstream Stresses to Drive Metastasis

    29 shares
    Share 12 Tweet 7
  • Laparoscopic Colectomy Cuts Surgical Site Infection Risk in Obese Adults

    29 shares
    Share 12 Tweet 7
  • Aging-Related Immune Cell Imbalances Linked to Subclinical Coronary Artery Disease

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Numerical Models Show Fibers Boost Polymer-Reinforced Concrete Beam Flexural Performance

Carbon Nanotubes and Alkali Treatment Boost Hemp Composite Fracture Resistance by Eighty Percent

Three-Dimensional Tumor Spheroids Uncover Critical Barriers Limiting Nanoparticle Cancer Theranostics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.